Abingdon Health Announces Substantial Revenue Growth
Company Announcements

Abingdon Health Announces Substantial Revenue Growth

Abingdon Health PLC (GB:ABDX) has released an update.

Abingdon Health PLC has reported an impressive 52% revenue increase in FY 2024 compared to the previous year, achieving £6.1m, with a strong H2 performance and cashflow positivity in Q4. The company, a leading international lateral flow CDMO, has expanded its capabilities with the acquisition of regulatory consultancy IVDeology and launched new self-test products under the Boots brand. Looking ahead, the Board is optimistic about sustaining robust revenue growth into FY 2025.

For further insights into GB:ABDX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskAbingdon Health PLC Announces Upcoming AGM and Services Overview
TipRanks UK Auto-Generated NewsdeskAbingdon Health Expands Operations into the US
TipRanks UK Auto-Generated NewsdeskAbingdon Health Reports Strong Growth and Expansion
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App